Abstract
Tumor targeted therapy has brought a new hope to the cancer patients. With the recent advances in nanotechnology and growing knowledge on unique cancer biomarkers, it is now possible to manipulate the surface architecture of polymeric nanoscale delivery systems with targeting moieties, such as antibodies, antibody fragments, specific molecules, small peptides, RNA aptamers etc. to target specific receptors and antigens present exclusively or overexpressed on the tumor cell surface or on the tumor endothelial cell surface. These modified polymeric nanoparticles deliver the loaded chemotherapeutics preferentially to the tumor tissue and not to the healthy tissue. This ensures highly targeted treatment without severe side effects which are normally experienced by the cancer patients in case of conventional chemotherapy. Such specifically constructed polymeric nanocarriers with improved tumor targeting profile are now regarded as engineered polymeric nanoparticles, which have become one of the prime areas of drug delivery research in recent times. This review describes specific approaches used in recent years to construct engineered polymeric nanoparticles, their emerging potential for cancer therapy and recent advances in tumor targeting. An equal attention has been devoted to the fundamental problems encountered in practical fields which limit their clinical use and industrial production.
Keywords: Active targeting, challenges, monoclonal antibody, polymeric nanoparticles, receptor, tumor targeting.
Current Pharmaceutical Biotechnology
Title:Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles
Volume: 14 Issue: 15
Author(s): Biswajit Mukherjee, Bhabani S. Satapathy, Laboni Mondal, Niladri S. Dey and Ruma Maji
Affiliation:
Keywords: Active targeting, challenges, monoclonal antibody, polymeric nanoparticles, receptor, tumor targeting.
Abstract: Tumor targeted therapy has brought a new hope to the cancer patients. With the recent advances in nanotechnology and growing knowledge on unique cancer biomarkers, it is now possible to manipulate the surface architecture of polymeric nanoscale delivery systems with targeting moieties, such as antibodies, antibody fragments, specific molecules, small peptides, RNA aptamers etc. to target specific receptors and antigens present exclusively or overexpressed on the tumor cell surface or on the tumor endothelial cell surface. These modified polymeric nanoparticles deliver the loaded chemotherapeutics preferentially to the tumor tissue and not to the healthy tissue. This ensures highly targeted treatment without severe side effects which are normally experienced by the cancer patients in case of conventional chemotherapy. Such specifically constructed polymeric nanocarriers with improved tumor targeting profile are now regarded as engineered polymeric nanoparticles, which have become one of the prime areas of drug delivery research in recent times. This review describes specific approaches used in recent years to construct engineered polymeric nanoparticles, their emerging potential for cancer therapy and recent advances in tumor targeting. An equal attention has been devoted to the fundamental problems encountered in practical fields which limit their clinical use and industrial production.
Export Options
About this article
Cite this article as:
Mukherjee Biswajit, Satapathy S. Bhabani, Mondal Laboni, Dey S. Niladri and Maji Ruma, Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles, Current Pharmaceutical Biotechnology 2013; 14 (15) . https://dx.doi.org/10.2174/1389201015666140608143235
DOI https://dx.doi.org/10.2174/1389201015666140608143235 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The ARRONAX Project
Current Radiopharmaceuticals CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Toxic Metals in Herbal Medicines. A Review
Current Bioactive Compounds Computed Tomographic Evaluation of Colonic Diverticulum Complications
Current Medical Imaging MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Current Medicinal Chemistry Vesicle Trafficking, Autophagy and Nanoparticles: A Brief Review
Current Nanomedicine Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies
Current Nanoscience Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Look Into My Onco-forest - Review of Plant Natural Products with Anticancer Activity
Current Topics in Medicinal Chemistry Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents
Recent Patents on CNS Drug Discovery (Discontinued) Needle in a Haystack: Targeting Specific Glucuronidases Amid the Human Microbiome
Current Enzyme Inhibition Drug Metabolism and Pharmacokinetics in Support of Drug Design
Current Pharmaceutical Design Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases
Current Diabetes Reviews Medication Conveyance Through Nose: Factors Affecting and Novel Applications
Drug Delivery Letters Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Anti-Cancer Agents in Medicinal Chemistry Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Current Pharmaceutical Biotechnology Promotion of Cortico-Cerebral Precursors Expansion by Artificial pri-miRNAs Targeted Against the Emx2 Locus
Current Gene Therapy Cancer Stem Cell Markers in Nasopharyngeal Carcinoma and Its Relevance for Therapy
Current Traditional Medicine